Precise blood diagnostics improve treatment outcome in non-small cell lung cancer patients
Non-small cell lung carcinoma is a particularly aggressive type of lung cancer. Tumor cells and tumor DNA (ctDNA) in the blood of patients with the disease can be analyzed by means of liquid biopsy…
